Malaria

$755 million*

Minimum Requirement for American Leadership

 
The malaria accounts support implementation of malaria prevention and treatment activities, the purchase of anti-malarial tools, and development of malaria vaccines, and other malaria-related research. These investments also leverage investments in other global health accounts.

Download PDF

Justification for Funding

  • Malaria is caused by mosquito bites infected with the malaria parasite. Half of the world’s population lives in areas at risk of malaria infection.
  • In 2016, there were an estimated 216 million new cases of malaria, 5 million more than 2015. Approximately 445,000 people died from malaria worldwide. One child dies every two minutes.
  • Interventions such as insecticide-treated nets, indoor residual spraying, and antimalarial medication  reduce malaria mortality by 62% worldwide between 2000 and 2016, 69% among children under age five in sub-Saharan Africa. Bed nets accounted for 68% of the malaria cases prevented since 2001.

Cost of Cuts Below $755 Million

President and Congress Budget Comparison

       Congressional Budget   

       President's Budget Request (Base + OCO)

  • Cuts to the malaria accounts could compromise progress made to date towards preventing, controlling, and eliminating malaria.
  • Rolling back funding could similarly compromise efforts in research and development as drug- and insecticide-resistance grows, thereby potentially having an unintended deleterious impact on our future anti-malarial efforts.
  • Studies show that a decrease in malaria morbidity and mortality rates increases GDP in the respective countries of which malaria funding in invested.

 

$755 million

Opportunity to Catalyze American Leadership

 

Justification for Full Funding

  • Cuts to the malaria accounts could compromise progress made to date towards preventing, controlling, and eliminating malaria.
  • Rolling back funding could similarly compromise efforts in research and development as drug- and insecticide-resistance grows, thereby potentially having an unintended deleterious impact on our future anti-malarial efforts.
  • Studies show that a decrease in malaria morbidity and mortality rates increases GDP in the respective countries of which malaria funding in invested.

Impact of Full Funding

*Enacted FY18 Omnibus Appropriation

For more information, please contact: Soshana Hashmie, shashmie@interaction.org

Choose to Invest:   2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012